Infection control: evidence-based common sense. by Dancer, Stephanie J.
+ MODEL
Infection, Disease & Health (2016) xx, 1e7Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.journals .e lsevier .com/infect ion-
disease-and-health/Discussion paper
Infection control: Evidence-based common sense
Stephanie J. Dancer a,b,*a NHS Lanarkshire, Scotland, UK
b Edinburgh Napier University, Scotland, UK





Antimicrobial agents* Corresponding author. Dept. of Mi
584350.
E-mail address: stephanie.dancer@
Please cite this article in press as:
http://dx.doi.org/10.1016/j.idh.201
http://dx.doi.org/10.1016/j.idh.2016
2468-0451/ª 2016 Australasian CollegAbstract When compared against classical sciences, infection control is very much the ‘new
kid-on-the-block’. This means that activities directed by infection prevention and control are
more likely to reflect ‘common sense’ rather than robust evidence. Indeed, hand hygiene,
isolation, screening, decontamination and cleaning remain hotly debated, especially the cur-
rent vogue for bathing patients in antiseptics. So, which of these provide measurable benefit,
and which do not? And why is it important? Do we actually need irrefutable evidence for the
advice that we dispel on a daily basis? This opinion piece examines the main components of
a modern day infection control service and assesses their worth from a mainly UK perspective.
The findings suggest that the framework for preventing infection is structurally sound, despite
the lack of evidence. Biological sciences, by their very nature, do not easily fit into neat equa-
tions; they remain subject to measurement variables, tempered by patient status and micro-
scopic pathogens. Despite this, numerous reports from healthcare facilities all over the world
stand testimony to basic hygiene, particularly when confronted by outbreaks. Managers and
others who seek to undermine traditional infection control practices should be challenged,
particularly when imposing knee-jerk policies for which there is no evidence at all. Given
the insidious creep of antimicrobial resistance, infection prevention and control will inevitably
assume the status it has hitherto been denied. Common sense, however defined, eventually
turns into scientific evidence at some stage but this progression relies upon continued accumu-
lation, evaluation and integration of evidence by professionals and policy makers.
ª 2016 Australasian College for Infection Prevention and Control. Published by Elsevier B.V. All
rights reserved.
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http://dx.doi.org/10.1016/j.idh.201 Screening identifies an unknown reservoir of colonised patients. You can’t control what you
don’t know about!
 Accurate surveillance permits analyses of infection prevention strategies.
 Making senior managers responsible for infection control creates an infection control ethos
throughout the institution.Introduction
Controlling infection has long been recognised as key to
good health. Over the past century, doctors have discov-
ered how to isolate and identify microbes of human inter-
est, along with their reservoirs and major modes of
transmission. Tracing the origin of these pathogens and
interrupting spread between environmental, non-human
and human reservoirs underpins the basis of infection pre-
vention and control practiced in today’s hospitals.
The first UK Infection Control nurses were appointed in
the late 1950’s; just as the first national infection control
guidelines were published in 1959 [1]. The trigger for these
was a decade or more of problems with the ‘hospital
staphylococcus’, an organism wreaking havoc in surgical
wards and furthermore becoming increasingly resistant to
penicillin [2]. The staphylococcal pioneers of the day
quickly established the epidemiology of ubiquitous Staph-
ylococcus aureus, including human carriage, role of the air
and environmental longevity [3]. The infection control
response in hospitals reflected burgeoning knowledge of S.
aureus and its reservoirs, and endorsed a staple diet of
patient isolation, screening, hand washing, natural venti-
lation and cleaning [3]. These activities relied heavily on
common sense, since there was little in the way of evidence
at the time. It wasn’t until 1985, with the publication of the
SENIC study, that definitive surveillance data demonstrated
tangible benefits of infection control in hospitals [4]. Since
then, the speciality of infection prevention and control is
recognized as a fundamental necessity for all healthcare
institutions, with increasing numbers of staff, policies,
protocols and guidelines providing a framework for
delivery.
How much progress have we made, then, toward
securing a robust evidence base for infection prevention
activities in hospitals over the last 50 years? The answer to
that is very little, if one considers the comments from
recent reviews [5]. Studies examining much of what we do
in the name of infection control concludes that evidence
supporting individual components of an infection preven-
tion programme is piecemeal and poor quality, and even
the evidence for ‘bundles’ of interventions fares little
better. The whole is still questionable, subject to con-
founding, bias, quality and scale.
Following outbreaks of specific organisms, the public
made hospital-acquired infection an electoral issue in the
UK [6]. This led to the introduction of targets for key
pathogens, with responsibility devolved to healthcare
managers [7,8]. The target culture has flourished to incor-
porate hand hygiene compliance and environmental in-
spections, along with directives on doctor’s dress, watches,
vases of flowers, magazines and toys in the waiting roomDancer SJ, Infection control: Evi
6.10.003[9,10]. On the wards, clinical staff live in fear of ‘zero
tolerance’ of their hand washing skills, with doctors
themselves accused of scruffiness and suspect personal
hygiene [11]. While these interventions have been imple-
mented in the name of infection control, they lack rigorous
studies and merely showcase the predictable knee-jerk
response from policy makers charged with public health
responsibilities. They also intimate what might happen
when the antibiotics finally run out.
Hand hygiene
Hand hygiene itself, the most obvious, the oldest (and
simplest) of all infection control activities has a shaky lead
over most other interventions from the evidence base
viewpoint [12]. Perhaps because it is so simple, it has
attracted funding, research and political support. It cannot
be argued that new build hospitals with plenty of spare
rooms and state of the art ventilation, are a lot more
expensive than providing bottles of alcohol gel. Further-
more, hygiene misdemeanours are firmly in the hands of
clinical staff and far removed from government offices. The
hand hygiene proponents claim that their efforts saved the
UK from MRSA, but one only has to examine the data to see
that there were many other interventions introduced over
the same time period that could all have contributed to-
wards falling rates of MRSA bacteraemias [13,14]. These
include surveillance programmes, rapid molecular tests,
antibiotic prescribing policies, the ‘deep clean’ initiative,
and screening all patient admissions for MRSA. While some,
or all, may have contributed towards decreased MRSA
rates, no effect has been seen on rates of multiply-resistant
coliforms, vancomycin-resistant enterococci or S. aureus
bacteraemias [14]. The latter is perhaps the real thorn in
the UK hand hygiene story, since all the emphasis on hand
hygiene and extra gel failed to impact on rates of a close
epidemiological relation of MRSA [13,14].
Screening
Universal screening for MRSA carriage with subsequent
decolonisation has almost certainly had a beneficial effect
on MRSA carriage and infection rates [14,15]. The MSSA
bacteraemia rate might also have decreased, as it has in
Australia, if patients had been screened for MSSA as well as
for MRSA [14,16]. In the UK, screening swabs arriving in the
microbiology laboratory are plated onto MRSA chromogenic
agar, which cannot support the growth of methicillin-
susceptible S. aureus (MSSA). Thus, infection control staff
readily identify patients with MRSA and treat accordingly,
while those with MSSA remain unidentified. Patients aredence-based common sense, Infection, Disease & Health (2016),
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those requiring surgical intervention [17].
It has long been known that you can’t control what you
don’t know about, so screening patients (and staff) for a
variety of pathogens remains a popular pastime for well-
resourced institutions. Many hospitals are now introducing
targeted screening for carbapenemase-producing co-
liforms, since these organisms are essentially untreatable
and constitute a significant risk for onward transmission.
Patient screening is not without critique; although heavily
defended if the evidence base is challenged [18e21]. The
decolonisation programmes offered to carrier patients have
also been criticised; for lack of clinical benefit and concern
over increasing resistance or tolerance to the agents used
in the topical clearance regimens [15,18,22]. Indeed, the
current vogue for bathing everyone with antiseptics,
notably chlorhexidine, has ignited much discussion with, as
yet, no clear decision to help policy makers [23].
Isolation
Once a patient has been identified with a potentially
transmissible pathogen, they are usually isolated in a side-
room, preferably with adjoining bathroom. Once again,
there is little substantial evidence to support this type of
segregation from the infection prevention point of view,
while there is evidence to show that isolated patients tend
to suffer from loneliness and reduced clinical attention
[15,22,24]. Indeed, understaffed wards cannot provide the
nursing care required for isolated patients since they are
not continually observed. Keeping the door of an isolation
room closed ought to be an important part of the package,
as well as donning the usual barrier protection before entry
[15]. There is little evidence for either. Doors are habitually
left open, which encourages staff (and visitors) to enter
without taking additional precautions. In that case,
isolating a patient acts as little more than a visual reminder
that they have a transmissible infection rather than a
serious attempt at curtailing onward transmission.
There is another facet to infection prevention involving
single-room occupancy, and that is proof that patients
accommodated in a room which previously held an infected
patient are more likely to acquire the same pathogen as
that of the prior occupant [25]. While this offers a comment
on hospital cleaning standards, or even the possibility of
airborne transmission, it also suggests that the risk of
acquiring an infection persists e regardless of any local
hand hygiene or barrier nursing endeavours.
Barrier protection
Plastic gloves and aprons are provided in most healthcare
facilities for dealing with infected or colonised patients.
These will not protect staff from acquiring pathogens on
their own skin, clothes or uniforms, but, as with isolation
rooms, they do offer token recognition towards infection
control. Staff wearing barrier protection remind visitors as
well as themselves that some patients and activities are
deemed high risk for infection. Colour coding in the inten-
sive care unit, for example, allows the nurse in charge to
spot a visitor to the ‘wrong’ bed, should staff encroachPlease cite this article in press as: Dancer SJ, Infection control: Evi
http://dx.doi.org/10.1016/j.idh.2016.10.003upon a patient zone not allocated to them for care. The
biggest problem with glove use is that the wearer assumes
that they are impervious to hospital germs, which is not
necessarily the case. Most brands are at risk of microscopic
holes or tearing, and even careful removal invariably con-
taminates staff hands. Whatever material is used, gloves
are still able to acquire hospital pathogens and spread them
through touch [26,27]. Thus, hand hygiene is less of a pri-
ority while the gloves stay on and this may itself lead to
transmission events [26,28]. Staff subconsciously view
gloves as barrier protection primarily for themselves, and
not for patients, and this clearly compromises patient
centred care.
Cleaning
Hospital cleaning has also come in for intense criticism,
especially following the impromptu ‘Deep Clean’ of English
hospitals [29]. Those who direct healthcare strategies still
do not understand the removal of dirt, or its significance,
probably because cleaning remains an undervalued
component of infection prevention [30]. Yet, it is a funda-
mental necessity for all healthcare environments and
equally as important as hand hygiene [31]. Hands certainly
transmit germs to patients but they have to make contact
with a reservoir on a hand-touch site before they can do
that. If the surface area of all the hands on a ward
(including staff, patients and visitors) is calculated and
compared against the surface area of all hand-touch sites
on that ward, one can arguably demonstrate a tangible
measure of the relative importance of both [14]. Is there
evidence to support surface cleaning in hospitals? Yes,
plenty, particularly studies that combine cleaning with
other initiatives, including hand hygiene [25,32e34].
Changing societal views on cleaning hands, including the
motivation to actually do it, is a lot more difficult than
implementing an environmental cleaning specification,
even if the latter requires monitoring and feed-back
[30,35].
Increased attention on the role of the healthcare envi-
ronment in transmitting hospital pathogens has awakened
interest from business and industry, with strategies aimed
at superseding traditional manual cleaning with detergent
and water [36]. Novel biocides and cleaning products,
antimicrobial coatings, auditing practices and automated
equipment are widely accessible, but most have not been
comprehensively assessed against patient outcome nor
subjected to appropriate cost-benefit analyses [37]. It is
singularly unhelpful when studies showcasing a new prod-
uct claim patient benefit but are then found to be
confounded by concurrent infection control and/or anti-
microbial stewardship initiatives [37].
Bundles
So-called ‘bundles’ are collections of different activities
designed to reduce HAI for a particular intervention such as
catheter care, a surgical procedure or intubation of a pa-
tient needing ventilatory support. They do seem to work,
because carefully chosen and well-maintained bundle
practices result in less infection among patients [38,39]. Ofdence-based common sense, Infection, Disease & Health (2016),
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assessed nor compared against any other intervention. If a
bundle is small and contains only the very best evidence,
notably better outcomes are achieved. It is also possible
that success is dependent not just on choice of component
but on compliance monitoring, since interventions that do
not work may not have been reliably implemented [40]. The
whole point of the bundle is to drive compliance, especially
if results of the intervention are monitored and fed back.
To a certain extent, ‘bundles’ of infection control activ-
ities are an excuse for lack of evidence for each component
[41]. Since there is so little robust evidence for many of the
things performed in the name of infection control, bundles
represent a best guess at the current time, even if some of
them turn out to be a spectacular waste of money. There is
also a risk that some of the elements might do more harm
than good, for example, universal application of antiseptics,
antibiotics, or other prophylactic agents [40,42,43].
Surveillance
The basis for all infection prevention strategies is reliable
surveillance [44]. Without clearly defined incidence data
collected over time, infection trends cannot be identified or
used correctly to inform control strategies. Accurate sur-
veillance data is also dependent upon the availability of
local resources, since any deficit in trained personnel and/or
microbiology services may compromise meaningful surveil-
lance. If there is access to an appropriate laboratory, it is
essential to ensure that samples are processed efficiently
with optimal recovery of key organisms and that transport
and storage media are organised to maintain viability.
Otherwise, bias is introduced that could skew the data. In
the UK, national surveillance centres and reference labora-
tories have been set up for the express purpose of capturing
specific pathogens and reporting surveillance trends [8].
These are published regularly for the benefit of microbiol-
ogists, public health, government and the public. The UK
also contributes towards several surveillance systems
established for European countries, including antimicrobial
consumption trends [45,46]. However, comparing and con-
trasting HAI, antimicrobial resistance and consumption rates
across the world, so important for global targets and action,
are not currently available. Since resistance mechanisms
travel across borders at liberty, courtesy of international
travel, far distant policy makers need to work together to
understand evolving threats from resistant pathogens [47].
Managers’ role
Whilst effective infection control undoubtedly saves
money, there remains persistent conflict between eco-
nomic restraints and the principles underlying basic infec-
tion prevention [48]. Managers seek to run a hospital along
the lines of an industrial business, with 100% bed occu-
pancy, increasing turnover and yet more targets imposed
on rapid processing and quality ‘end-products’. However,
patients are neither uniform nor standardised, and
their myriad healthcare needs do not necessarily fit into
a pre-determined production line, either. The whole is
confounded by the fact that it is impossible to control,Please cite this article in press as: Dancer SJ, Infection control: Evi
http://dx.doi.org/10.1016/j.idh.2016.10.003let alone prevent, infection in a hospital filled to capacity,
understaffed, with open visiting, lengthening waiting times
and subject to government targets [49]. What meagre evi-
dence we have, on safe bed occupancy rates, hand hy-
giene, screening, cleaning and so on, is automatically
rendered ineffective for a hospital bursting at the seams
[50]. Within the soup of human proximity, antimicrobial
exposure, inadequate cleaning and artificial ventilation,
antibiotic-resistant organisms of the day happily tutor the
multi-drug resistant pathogens of tomorrow.
Managers keen to reduce costs are centralising health-
care facilities without considering clinical risk review as
justification for service cuts. Should this concern an
underutilised clinical service or a rare test, for example,
then centralisation is clearly rational, but this is not always
the case. The centralisation of accident and emergency
departments, basic laboratory services or routine surgical
specialities erodes the quality of the clinical service
without necessarily saving money [51]. This also forces
specimens, staff and/or patients to travel much longer
distances than they would have done, sometimes with
detrimental effect. Some healthcare boards or regions have
also centralised infection control services, which increases
response time to significant incidents as well as encour-
aging the spread of antimicrobial resistance and risk of
outbreaks. It is difficult to defend an on-site infection
control presence when this ‘teenage’ science does not yet
have the evidence it needs to defend local services or give
it the priority it deserves.Best practice based on current evidence
So what constitutes effective prevention and infection, and
how do we establish best practice in our hospitals? [52]
Microbiologists and infection control practitioners tacitly
assume that, despite the lack of evidence, our infection
control framework is structurally sound. Fleshing out the
detail will take time, as always with a new science, but the
undeniable spectre of untreatable infection provides an
increasingly strong focus [53]. There is nothing wrong with
current components of the infection prevention mantra,
other than the irritating and hysterical add-ons that will
fade with the evidence to come. Basic hygiene has stood
the test of time, from the Greeks and their silver pots, to
Florence Nightingale and her open windows [54]. It’s a fact
of life that there may have to be a fatal outbreak of pan-
resistant microbes in our overcrowded hospitals before
general acceptance of safe bed occupancy rates, for
example, but the things we do now to stop pathogens
spreading between patients are tried and tested and should
continue (Highlights) [55].
One particular activity, not yet mentioned, has profound
effects on the incidence and prevalence of many of the
pathogens associated with HAI. This is antimicrobial stew-
ardship, which is a rather pompous term for appropriate
management of antiinfective prescribing. Like cleaning,
stewardship is easier to implement than hand hygiene, and
it has a rapid and measurable impact on resistance rates of
hospital pathogens, including Clostridium difficile. [56,57]
Provided one can safely discard the possibility of septic
shock, it is entirely justifiable to terminate an antibioticdence-based common sense, Infection, Disease & Health (2016),
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specimens without the pressure from potent antibiotics
means that the laboratory has a chance of isolating the
pathogen and thus improves future therapeutic choice.
Indeed, in true paradoxical form, patients often get better
if the clinician has the courage to reign in antimicrobial
prescribing. Reducing overall antibiotic consumption
throughout hospital, community, and across an entire
country, means a few more years’ insurance for the prudent
before pan-resistance threatens [58,59].
And for infection control professionals? What can we do
to defend patients against the germs? Perhaps it is time to
refocus on a culture of hygiene for our patients, our
families and ourselves. Older colleagues may remember
how things were before the explosion of antimicrobial
agents last century but younger folk will have grown up
with the mantra of ‘a pill for every ill’. Medical, and
indeed, all healthcare students are not necessarily taught
much about hygiene and its definition at college or uni-
versity [11,14]. The pendulum favouring the importance of
‘clean’ is beginning to swing back, and faced with dimin-
ishing antibiotic options, it’s not difficult to see why [60].
All healthcare practitioners should keep faith with com-
mon sense surrounding the definition of hygiene and stick
with traditional values. Evidence for what we do in the
name of infection prevention and control will undoubtedly
appear as antibiotic therapies dissipate. While the 20th
century introduced life-saving anti-infectives and vac-
cines, the 21st will herald infection prevention and con-
trol, all underpinned by formative studies on pathogen
transmission [48].
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